BRIEF-EMA's CHMP Starts Evaluating Application For Authorisation Of Adapted Version Of Spikevax
European Medicines Agency:
* EMA: EMA'S CHMP STARTED EVALUATING AN APPLICATION FOR THE AUTHORISATION OF AN ADAPTED VERSION OF SPIKEVAX: 22/07/2022
European Medicines Agency:
* EMA: EMA'S CHMP STARTED EVALUATING AN APPLICATION FOR THE AUTHORISATION OF AN ADAPTED VERSION OF SPIKEVAX: 22/07/2022
Google News
RSS
Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.
By submitting, you agree that we may use your email address to respond.
